Biologically active noncalcemic analogs of 1alpha,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl
about
Antitumor effects of vitamin D analogs on hamster and mouse melanoma cell lines in relation to melanin pigmentation.Supplementation by vitamin D compounds does not affect colonic tumor development in vitamin D sufficient murine models.Synthesis and photo-conversion of androsta- and pregna-5,7-dienes to vitamin D3-like derivatives.Photo-conversion of two epimers (20R and 20S) of pregna-5,7-diene-3beta, 17alpha, 20-triol and their bioactivity in melanoma cells.Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.Novel vitamin D photoproducts and their precursors in the skin.A new role for vitamin D receptor activation in chronic kidney disease.Psoriasis care: new and emerging pharmacologic trends.Recent developments of 19-nor-1,25-dihydroxyvitamin D3 analogues.Synthesis and photochemical transformation of 3β,21-dihydroxypregna-5,7-dien-20-one to novel secosteroids that show anti-melanoma activity.Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia.A molecular description of ligand binding to the two overlapping binding pockets of the nuclear vitamin D receptor (VDR): structure-function implications.Differential activity of 2-methylene-19-nor vitamin D analogs on growth factor gene expression in rhino mouse skin and comparison to all-trans retinoic acid.Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.Antiproliferative Activity of Non-Calcemic Vitamin D Analogs on Human Melanoma Lines in Relation to VDR and PDIA3 Receptors
P2860
Q35585386-CA7D2734-2037-4910-BCA3-1CE9B8B7213CQ35808511-4D6C974A-D0F6-4404-A89E-D62747B58170Q37003659-6E5EFF25-BF13-4D51-8726-276B944CD48CQ37074580-FF229234-C7CF-44BE-B5C7-CA0BDD59AAC4Q37481349-759CCE86-58E2-4FA1-9FC2-F6EFF7EEDDB6Q37499996-C6372644-0004-44FD-94E2-08EF21032C7DQ37558961-3D6D80FE-2E44-4037-8358-5BD2F0A49C85Q37757329-A4F2ECE7-55C4-401D-AA44-D29403AE4A1FQ38115994-258CD003-77C3-477D-8EDC-F90CE5BBDFF3Q39633004-6E0111D1-6D78-476C-995E-EAF8D97A8DBCQ41436449-A2B176A0-6DF6-4B02-A3DD-A6DDED00D76BQ42131334-9D162F93-BB98-4436-AFC9-266AFCA3688AQ47123884-CCCCE33F-E37E-4638-81A6-B260CE6A43E4Q48218051-62822A28-37EB-4211-B5E9-36C098B81725Q58779190-508DA2B9-F623-4E8B-8937-546C0D6BD0E9
P2860
Biologically active noncalcemic analogs of 1alpha,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Biologically active noncalcemi ...... e chain containing no hydroxyl
@ast
Biologically active noncalcemi ...... e chain containing no hydroxyl
@en
type
label
Biologically active noncalcemi ...... e chain containing no hydroxyl
@ast
Biologically active noncalcemi ...... e chain containing no hydroxyl
@en
prefLabel
Biologically active noncalcemi ...... e chain containing no hydroxyl
@ast
Biologically active noncalcemi ...... e chain containing no hydroxyl
@en
P2093
P2860
P356
P1476
Biologically active noncalcemi ...... e chain containing no hydroxyl
@en
P2093
Hector F DeLuca
Jean M Prahl
Lori A Plum
Margaret Clagett-Dame
Rafal R Sicinski
Sumithra Gowlugari
Xiaohong Ma
P2860
P304
P356
10.1073/PNAS.0401656101
P407
P577
2004-04-26T00:00:00Z